Flibanserin: A controversial drug for female hypoactive sexual desire disorder
Sexual functioning is an integral part of human life. Female sexual dysfunction (FSD) adversely affects quality of life and general well-being. The Food and Drug Administration recently approved flibanserin, for treatment of female hypoactive sexual desire disorder (HSDD), regarded as the most commo...
Enregistré dans:
| Auteurs principaux: | , |
|---|---|
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
Wolters Kluwer Medknow Publications
2018-01-01
|
| Collection: | Industrial Psychiatry Journal |
| Sujets: | |
| Accès en ligne: | http://www.industrialpsychiatry.org/article.asp?issn=0972-6748;year=2018;volume=27;issue=1;spage=154;epage=157;aulast=Baid |
| Tags: |
Pas de tags, Soyez le premier à ajouter un tag!
|